← Evidence map

ArticleCommunications biology2026

Targeting HAS2 to enhance anti-tumor immunity in pancreatic cancer via PD-L1 regulation.

Chuifang Kong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 41951812